Actively Recruiting
Effectiveness of Percutaneous Electrolysis Treatment Targeting the Muscle-Fascia Chain in Chronic Plantar Fasciitis: A Randomized Controlled Study
Led by Sivas State Hospital · Updated on 2025-12-19
50
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying chronic plantar fasciitis in adults by comparing two treatment approaches that combine a conventional exercise program with percutaneous electrolysis. The study aims to evaluate whether applying percutaneous electrolysis to both the plantar fascia and the myofascial trigger points in the gastrosoleus muscles improves treatment effectiveness compared to applying it only to the plantar fascia. This randomized controlled trial excludes participants with certain medical conditions and requires confirmation of plantar fasciitis by clinical symptoms and ultrasound imaging. Participants will be randomly assigned to one of two groups. Both groups follow a home-based exercise program including stretching of the plantar fascia and Achilles tendon, rolling exercises, and towel-grasping to strengthen foot muscles. One group will receive ultrasound-guided percutaneous electrolysis on the plantar fascia alone, while the other group will receive the same electrolysis treatment on both the plantar fascia and trigger points in the gastrosoleus muscles. Treatments occur three times on days 1, 8, and 14 using fine acupuncture needles and a specialized device delivering a low-intensity galvanic current. Throughout the study, participants will be evaluated for pain intensity, pressure pain threshold, foot function, tissue changes via ultrasound, and maximum pain-free standing and walking times. These assessments take place before treatment, immediately after the last treatment session (about two weeks), and three months after starting treatment. The study collects detailed data to understand differences in outcomes between the two treatment strategies over time, with monitoring continuing until April 2026.
CONDITIONS
Brief Title
Percutaneous Electrolysis Targeting the Muscle-Fascia Chain for Treating Chronic Plantar Fasciitis in Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged between 18 and 70 years
- Symptoms of plantar fasciitis lasting at least 6 weeks
- Clinical diagnosis of plantar fasciitis confirmed by sharp heel pain and ultrasound showing plantar fascia thickness greater than 4 mm
- No prior medical treatment for plantar fasciitis
- Agreement not to use anti-inflammatory drugs during treatment
- Normal blood laboratory results
- No known acute or chronic inflammatory disease
- Sufficient education level to understand treatment and procedures
- Ability to complete treatment evaluation forms
You will not qualify if you...
- Presence of malignancy or active infection
- History of systemic inflammatory rheumatic disease
- Trauma, skin lesions, infection, or open wounds on the foot
- Neuropathy, radiculopathy, or peripheral circulatory disorders
- Coagulopathy or use of warfarin
- Arthropathy or lower extremity deformities
- Sequelae of lower extremity fracture
- Presence of prosthesis, internal plate, screw fixation, cardiac pacemaker, or metal implant in the treatment area
- Conditions contraindicating physiotherapy, including pregnancy
- Metal allergy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 2 weeks
Participants receive a conventional home-based exercise program involving daily plantar fascia and Achilles tendon stretching, foot rolling, and towel-grasping exercises, combined with three sessions of ultrasound-guided percutaneous electrolysis on days 1, 8, and 14 targeting either the plantar fascia alone or both the plantar fascia and gastrosoleus muscles.
3 treatment visits on days 1, 8, and 14
Duration - Up to 3 months
Participants are monitored for changes in pain intensity, pressure pain threshold, functional status, ultrasound tissue parameters, and pain-free standing and walking time up to 3 months after treatment initiation.
1 follow-up visit at 3 months after treatment initiation
Trial Site Locations
Total: 1 location
1
Sivas Devlet Hastanesi
Sivas, Merkez, Turkey (Türkiye)
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here